Drug Recall: Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by
Lupin Pharmaceuticals Inc. · April 24, 2024
Reason for Recall
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Product Description
Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046, India, NDC 68180-722-04
Distribution
USA nationwide
States Affected
NATIONWIDE
Quantity Affected
17,040 bottles
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0497-2024
Status: terminated
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.